title: [Terminal care. II. Easing of symptoms of cancer patients. 5. Management of adverse effects of antineoplastic agents].
authors.forename: M
authors.initials: M
authors.lastname: Kurihara
authors.forename: M
authors.initials: M
authors.lastname: Matsukawa
authors.forename: W
authors.initials: W
authors.lastname: Yamamoto
authors.forename: A
authors.initials: A
authors.lastname: Sato
authors.forename: T
authors.initials: T
authors.lastname: Cho
authors.forename: S
authors.initials: S
authors.lastname: Akazawa
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D005767:Gastrointestinal Diseases / Q000139:chemically induced / Q000628:therapy*; D006331:Heart Diseases / Q000139:chemically induced / Q000628:therapy; D006402:Hematologic Diseases / Q000139:chemically induced / Q000628:therapy*; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced / Q000628:therapy; D008171:Lung Diseases / Q000139:chemically induced / Q000628:therapy
chemical_list: D000970:Antineoplastic Agents